Cargando…

Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation

OBJECTIVE: Recently, circulating donor-derive cell free DNA (dd-cfDNA) has gained growing attention in the field of solid organ transplantation. The aim of the study was to analyze circulating dd-cfDNA levels in graft rejection, ACR and AMR separately for each rejection type compared with non-reject...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yunhui, Liang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598712/ https://www.ncbi.nlm.nih.gov/pubmed/37885888 http://dx.doi.org/10.3389/fimmu.2023.1263389

Ejemplares similares

Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation
por: Keller, Michael, et al.
Publicado: (2021)

Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2023)

Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study
por: Zhang, Huanxi, et al.
Publicado: (2020)

Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation
por: Khush, Kiran K., et al.
Publicado: (2021)

Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation
por: Tanaka, Shin, et al.
Publicado: (2018)

Donor-Derived Cell-Free DNA (ddcf-DNA) and Acute Antibody-Mediated Rejection in Kidney Transplantation
por: Jaikaransingh, Vishal, et al.
Publicado: (2021)

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
por: Hurkmans, Daan P., et al.
Publicado: (2019)

Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data
por: Sayah, David, et al.
Publicado: (2020)

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation
por: Kim, Paul J., et al.
Publicado: (2022)

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
por: Rosenheck, Justin P., et al.
Publicado: (2022)

The number of donor HLA-derived T cell epitopes available for indirect antigen presentation determines the risk for vascular rejection after kidney transplantation
por: Betjes, Michiel G. H., et al.
Publicado: (2022)

Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
por: Aschauer, Constantin, et al.
Publicado: (2021)

Donor-Derived Cell-Free DNA and Active Rejection in Renal Allografts
por: Fernando, Edwin, et al.
Publicado: (2023)

Repeat kidney transplant recipients with active rejection have elevated donor‐derived cell‐free DNA
por: Mehta, Shikha G., et al.
Publicado: (2018)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation
por: Obrișcă, Bogdan, et al.
Publicado: (2022)

The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection
por: van Besouw, Nicole M., et al.
Publicado: (2019)

Careful clinical evaluation of donor fraction cell-free DNA in rejection surveillance after heart transplantation
por: Napoli, Claudio, et al.
Publicado: (2020)

Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts
por: Balam, Saidou, et al.
Publicado: (2022)

Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
por: Mantios, Evangelos, et al.
Publicado: (2023)

Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype
por: Sharon, Eilon, et al.
Publicado: (2017)

Circulating Donor-derived Cell-free DNA: A Novel Non-invasive Biomarker for Allograft Rejection in Vascularized Composite Allotransplantation
por: Rifkin, William J., et al.
Publicado: (2022)

Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients
por: Zhao, Dong, et al.
Publicado: (2021)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
por: Martuszewski, Adrian, et al.
Publicado: (2021)

Early Experience Using Donor-derived Cell-free DNA for Surveillance of Rejection Following Simultaneous Pancreas and Kidney Transplantation
por: Williams, Michael D., et al.
Publicado: (2022)

Observed elevated donor‐derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection
por: Afzal, Aasim, et al.
Publicado: (2021)

Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients – A Proof-of-Concept Study
por: Kamath, Megan, et al.
Publicado: (2022)

Polyfunctional donor-reactive T cells are associated with acute T-cell-mediated rejection of the kidney transplant
por: Litjens, Nicolle H R, et al.
Publicado: (2023)

The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Serum uric acid as a risk factor for rejection after deceased donor kidney transplantation: A mono-institutional analysis of paired kidneys
por: Zhang, Fuxun, et al.
Publicado: (2022)

Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation
por: Ventura-Aguiar, Pedro, et al.
Publicado: (2022)

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation
por: Agbor-Enoh, Sean, et al.
Publicado: (2019)

Single Center “Snapshot” Experience With Donor-Derived Cell-Free DNA After Lung Transplantation
por: Levine, Deborah Jo, et al.
Publicado: (2020)

Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation
por: Akifova, Aylin, et al.
Publicado: (2023)

Absolute quantification of donor‐derived cell‐free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study
por: Oellerich, Michael, et al.
Publicado: (2019)

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
por: Halloran, Philip F., et al.
Publicado: (2022)

Urine Donor–Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection
por: Chen, Xu-Tao, et al.
Publicado: (2020)

B Cell Immunity in Lung Transplant Rejection - Effector Mechanisms and Therapeutic Implications
por: Ohm, Birte, et al.
Publicado: (2022)

Elevated Circulating IL-10 Producing Breg, but Not Regulatory B Cell Levels, Restrain Antibody-Mediated Rejection After Kidney Transplantation
por: Luo, Yongsheng, et al.
Publicado: (2021)

Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients
por: Altuğ, Yücel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bk6l32s9vocv3dtpk41l8hofmv